Recent developments in health highlight key agreements between countries, drug approvals, corporate revenue growth, and ...

Caterpillar said Wednesday it anticipates that tariffs may increase its second-quarter costs by up to $350 million as its ...

The U.S. economy shrank at a 0.3% annual pace from January through March, first drop in three years. It was slowed by a surge ...

Novartis has reached an agreement to buy Regulus Therapeutics and its experimental therapy for autosomal dominant polycystic ...